Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
P. Gazzerro,A. Malfitano,9 Authors,M. Bifulco
2009 · DOI: 10.3892/OR_00000619
Oncology Report · 33 Citations
TLDR
The findings suggest that the combined synergic effect of SR141716 and oxaliplatin improves the blocking of colon cancer cell proliferation and merits further explorations in preclinical and clinical settings.